# NEOSTIGMINE METHYLSULFATE
> **ANDA216291** · Abbreviated New Drug Application (Generic) · Sponsor: DR REDDYS · Approved 2022-07-06
## Drug
- **FDA Application Number:** ANDA216291
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NEOSTIGMINE METHYLSULFATE
- **Generic name:** NEOSTIGMINE METHYLSULFATE
- **Active ingredients:** NEOSTIGMINE METHYLSULFATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** DR REDDYS
- **Manufacturer:** Dr.Reddys Laboratories Inc
- **First approval:** 2022-07-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216291)
---
*MORVS · CC0 1.0*